कृपया अन्य खोज का प्रयास करें
Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company’s pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action. Roquefort Therapeutics plc was incorporated in 2020 and is based in London, the United Kingdom.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Joanne Martin | - | 2023 | Member of Scientific Advisory Board |
Armand Keating | - | 2022 | Independent Chief Medical Officer & Member of Scientific Advisory Board |
Martin J. Evans | - | 2022 | Group Chief Scientific Officer & Executive Director |
Stephen Paul West | 50 | 2020 | Executive Chairman |
Trevor Ajanthan Reginald | - | 2022 | CEO & Executive Director |
Trevor Mervyn Jones | 81 | 2022 | Member of Scientific Advisory Board & Advisor to the Board |
Simon Sinclair | - | 2022 | Non-Executive Director |
Jean Marie Duvall | 63 | 2022 | Non-Executive Director |
Darrin Matthew Disley | 57 | 2022 | Non-Executive Director |
Michael Stein | 61 | 2021 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है